Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommadossi

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Nucleic Acids Symposium Series (2004)|September 9, 2008
Synthesis and antiviral evaluation of a seven-membered sugar ring nucleoside analog, 9-(5-deoxy-beta-D-allo-septanosyl)-adenineGwenaëlle Sizun, Jean-François Griffon, Ludovic Griffe, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapyRieneke M E van Praag, Elisabeth C M van Weert, Rolf P G van Heeswijk, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
The Journal of Infectious Diseases|March 9, 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study TeamR L Murphy, R M Gulick, V DeGruttola, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosineP A Furman, J Jeffrey, L L Kiefer, et al.
Antiviral Chemistry & Chemotherapy|August 31, 2001
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replicationL Placidi, A Faraj, A G Loi, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Anti-HBV specific beta-L-2'-deoxynucleosidesM L Bryant, E G Bridges, L Placidi, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Antiviral L-nucleosides specific for hepatitis B virus infectionM L Bryant, E G Bridges, L Placidi, et al.
Antiviral Chemistry & Chemotherapy|October 12, 2001
Antiviral beta-L-nucleosides specific for hepatitis B virus infectionD N Standring, E G Bridges, L Placidi, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Nucleic Acids Symposium Series (2004)|September 9, 2008
Synthesis and antiviral evaluation of a seven-membered sugar ring nucleoside analog, 9-(5-deoxy-beta-D-allo-septanosyl)-adenineGwenaëlle Sizun, Jean-François Griffon, Ludovic Griffe, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapyRieneke M E van Praag, Elisabeth C M van Weert, Rolf P G van Heeswijk, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
The Journal of Infectious Diseases|March 9, 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study TeamR L Murphy, R M Gulick, V DeGruttola, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosineP A Furman, J Jeffrey, L L Kiefer, et al.
Antiviral Chemistry & Chemotherapy|August 31, 2001
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replicationL Placidi, A Faraj, A G Loi, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Anti-HBV specific beta-L-2'-deoxynucleosidesM L Bryant, E G Bridges, L Placidi, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Antiviral L-nucleosides specific for hepatitis B virus infectionM L Bryant, E G Bridges, L Placidi, et al.
Antiviral Chemistry & Chemotherapy|October 12, 2001
Antiviral beta-L-nucleosides specific for hepatitis B virus infectionD N Standring, E G Bridges, L Placidi, et al.
Pageof 18